Trial intelligence / Profile preview

Taurine in Type 2 Diabetes

NCT04874012Phase 2Recruiting

Sponsor
Hospital de Clínicas de Porto Alegre
Start
Jun 2021
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of taurine in type 2 diabetes mellitus (T2DM), sponsored by Hospital de Clínicas de Porto Alegre. Started Jun 2021; status: recruiting.

02

Drugs

taurine
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT04874012.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04874012.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call